510(k) Report

510(k) · Cleared

Cleared

BD FlowSmart Set/MiniMed Pro-Set

K181718510(k) TraditionalCleared Oct 18, 2018111-day reviewClass II21 CFR 880.5440

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Becton, Dickinson and Company · FPA Set, Administration, Intravascular

Cleared on Oct 18, 2018 as substantially equivalent to K160651 (Becton, Dickinson and Company, 2016) after a 111-day review. Its family tree reaches back 5 generations to 2004. 1 of the 7 devices in its family, counting itself, has a Class I recall.

Decided
Oct 18, 2018
Review
111 days
Class
Class II
Product code
FPA
Recalls
None
Predicates
1

Its longest line of descent runs back 5 generations to K033290 (2004). 6 ancestors in all, the oldest K011071 (2001). No later device cites it as a predicate yet. 1 of the 7 devices in this family, counting this one, has a Class I recall.

  1. Root · 5 generations backK033290 Talon Infusion Set, Model IP XXXXIcu Medical, Inc. · 2004 · Recalled
  2. 4 generations backK130468 Orbit Infusion SetYpsomed AG · 2013
  3. 3 generations backK150059 BD FlowSmart SetBecton, Dickinson Company · 2015
  4. 2 generations backK153257 BD FlowSmart Set, MiniMed Pro-SetBecton, Dickinson and Company · 2015
  5. 1 generation backK160651 BD FlowSmart Set, MiniMed Pro-SetBecton, Dickinson and Company · 2016 · Recalled
  6. This deviceK181718 BD FlowSmart Set/MiniMed Pro-SetBecton, Dickinson and Company · 2018

Class I recalls in this family

View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K033290Talon Infusion Set, Model IP XXXXIcu Medical, Inc.20043
−4K130468Orbit Infusion SetYpsomed AG2013—
−3K150059BD FlowSmart SetBecton, Dickinson Company2015—
−2K153257BD FlowSmart Set, MiniMed Pro-SetBecton, Dickinson and Company2015—
−1K160651BD FlowSmart Set, MiniMed Pro-SetBecton, Dickinson and Company20162
0 (this device)K181718BD FlowSmart Set/MiniMed Pro-SetBecton, Dickinson and Company2018—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200111
FIG. 1 — Lineage of K181718, 2004–2018Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FPA device

  1. #1 K243841 Sparta Infusion Set for Insulinscore 13.4 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K160651BD FlowSmart Set, MiniMed Pro-Set
Summary page 4
…ular administration set) Product Code: FPA, FPK Legally marketed predicate devices to which substantial equivalence is being claimed: K160651: BD FlowSmart™ Set/MiniMed™ Pro-Set™ Device Description: The subject infusion set is a single use infusion administration set i…
Becton, Dickinson and Company20162

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (1 Class I)

No FDA recall names this device.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K011071Paradigm Quick-Set Infusion SetMaersk Medical A/S · 2001 · 4 generations back · ◆ in the 2001 ancestors bar of FIG. 11 Class I recall

What does this lineage say?

  • The line of descent spans 14 years and passes through 4 companies; a new generation was cleared every 2.1 years on median.
  • 3 of the 6 ancestors have a recall of any class; 1 has a Class I recall.

How does its category compare?

All FPA devices

FPA Set, Administration, Intravascular: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · FPA

11in 2025

2007: 162008: 182009: 102010: 232011: 122012: 212013: 132014: 222015: 172016: 122017: 172018: 42019: 72020: 102021: 132022: 142023: 142024: 72025: 112026 (partial year): 5
2007high 23 (2010) · low 4 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FPA

225in 2025

2007: 75 days median2008: 89 days median2009: 166 days median2010: 120 days median2011: 87 days median2012: 96 days median2013: 90 days median2014: 89 days median2015: 123 days median2016: 195 days median2017: 240 days median2018: 177 days median2019: 161 days median2020: 327 days median2021: 186 days median2022: 213 days median2023: 340 days median2024: 244 days median2025: 225 days median2026 (partial year): 266 days median
2007high 340 (2023) · low 75 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FPA

98in 2025

2007: 172008: 152009: 1662010: 582011: 282012: 16, 4 Class I2013: 642014: 242015: 62016: 102017: 132018: 42019: 132020: 1072021: 12022: 9, 5 Class I2023: 12, 4 Class I2024: 13, 1 Class I2025: 98, 1 Class I2026 (partial year): 10, 2 Class I
2007high 166 (2009) · low 1 (2021)2026

Class I (17 since 2007) Class II/III not classified

Adverse event reports per year · FPA

34,506in 2025

2007: 1,4992008: 1,9412009: 2,5122010: 2,5372011: 4,4072012: 4,9302013: 4,6512014: 4,6952015: 6,6252016: 8,4702017: 6,4622018: 6,5742019: 11,2272020: 9,5632021: 10,4142022: 13,3932023: 10,9162024: 47,2102025: 34,506
2007high 47,210 (2024) · low 1,499 (2007)2025

MAUDE reports naming product code FPA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071675171,499
20081889151,941
2009101661662,512
201023120582,537
20111287284,407
2012219616 (4)4,930
20131390644,651
20142289244,695
20151712366,625
201612195108,470
201717240136,462
2018417746,574
201971611311,227
2020103271079,563
202113186110,414
2022142139 (5)13,393
20231434012 (4)10,916
2024724413 (1)47,210
20251122598 (1)34,506
2026526610 (2)—

What is it indicated for?

The BD FlowSmart™ Set/MiniMed™ Pro-Set™ set is intended for the subcutaneous infusion of medication, including insulin, from an external infusion pump.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K181718: BD FlowSmart Set/MiniMed Pro-Set.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K181718

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026